NASDAQ:FBIOP

Fortress Biotech, Inc Earning Date

USA |NASDAQ |USD

FBIOP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Sep 30, 2021 (est) Jun 30, 2021 - $-0.04 $-0.20
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Sep 30, 2021 (est) Jun 30, 2021 - $11.59M $9.46M

Fortress Biotech, Inc's next estimated earnings date (based on same quarter last year's date) is Sep 30, 2021 for the fiscal quarter ending Jun 30, 2021.

FBIOP Earnings Date & History Chart

FBIOP Earnings Date & Revenue History

FBIOP Earnings History

|
Show More
Show More

FBIOP Revenue History

|
Show More
Show More

Fortress Biotech, Inc Next Earnings Date & Report

FBIOP Jun 2021 (FQ) Earnings Date & Report Preview

FBIOP's next estimated earnings date (based on same quarter last year's report date) is Sep 30, 2021 for the fiscal quarter ending Jun 30, 2021.

Fortress Biotech, Inc Previous Earnings Dates & Reports

FBIOP Previous Earnings Date & Report Recap: Mar 2021 (FQ)

Fortress Biotech, Inc's previous earnings date was Jun 30, 2021 for its fiscal quarter ended Mar 31, 2021.

FBIOP's earnings per share (EPS) was $-0.04.

The EPS was higher than the previous fiscal quarter (Dec 2020) by -59.95%, and higher than the same period a year before (Mar 2020) by -77.50%.

Revenues were $11.59M, down by -8.83% from the previous quarter , and down by -10.30% from the same period last year.

The company reported a net income of $-8.82M.

Free cash flow for the quarter was $-22.15M , compared to $-38.18M last quarter and $-23.67M a year before.

FBIOP ended the quarter with $87.35M in total debt, an increase of 48.49% compared to the previous quarter, and an increase of 2.30% compared to the same quarter a year before.

FBIOP Previous Earnings Date & Report Recap: Dec 2020 (FY)

Fortress Biotech, Inc's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

FBIOP's earnings per share (EPS) was $-0.57.

Revenues were $44.53M, up by 21.57% from previous year's revenue.

The company reported a net income of $-102.98M.

Fortress Biotech, Inc reported a free cash flow of $-85.61M for its fiscal year, compared to $-99.71M a year ago.

The company ended the fiscal year with $58.83M in total debt, a decrease of -31.95% compared to the previous year.